romurtide has been researched along with Corynebacterium-Infections* in 2 studies
2 other study(ies) available for romurtide and Corynebacterium-Infections
Article | Year |
---|---|
Experimental and clinical studies on the effects of synthetic muramyldipeptide derivatives on viral and opportunistic infections.
The efficacy of strearoyl-MDP derivatives, L18-MDP and MDP-Lys-18 against bacterial and viral infections in mice was examined. Both L18-MDP and MDP-Lys-L18 stimulated nonspecifically host-resistance against opportunistic infection with C. kutscheri in hydrocrotisone-treated mice against Sendai virus infection in mice. Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Corynebacterium Infections; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; Male; Mice; Mice, Inbred BALB C; Parainfluenza Virus 1, Human; Paramyxoviridae Infections; Time Factors | 1986 |
Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
Opportunistic corynebacteriosis was induced successfully by infection with Corynebacterium kutscheri in cortisone-treated mice and the ability of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine derivatives in phosphate buffered saline (PBS) solution or encapsulated into liposomes for restoring impaired resistance was examined. 6-O-Stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine (L18-MDP) in liposomes and N alpha-acetyl muramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine (MDP-Lys-L18) both in PBS solution and in liposomes were shown to restore depressed resistance to infection of C. kutscheri when injected intravenously before infection. Treatment with L18-MDP in cortisone-treated mice inhibited growth of C. kutscheri in the liver and kidney for as long as three days after infection. Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Cortisone; Corynebacterium Infections; Immunity, Innate; Male; Mice; Mice, Inbred BALB C | 1984 |